We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

80 hedge funds and large institutions have $27.8M invested in Tandem Diabetes Care in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 14

75% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 12

7% more funds holding

Funds holding: 75 → 80 (+5)

6% more capital invested

Capital invested by funds: $26.2M → $27.8M (+$1.56M)

0.71% more ownership

Funds ownership: 3.98% → 4.69% (+0.71%)

Holders
80
Holders Change
+5
Holders Change %
+6.67%
% of All Funds
1.99%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
28
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
FCM
Frontier Capital Management
Massachusetts
+$8.33M
2
WA
Wasatch Advisors
Utah
+$5.13M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$3.5M
4
BlackRock
BlackRock
New York
+$2.23M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$2.11M

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$591K
2
Bank of New York Mellon
Bank of New York Mellon
New York
-$316K
3
Renaissance Technologies
Renaissance Technologies
New York
-$302K
4
FA
FDx Advisors
Illinois
-$210K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$147K
Name Holding Trade Value Shares
Change 		Change in
Stake
FCM
1
Frontier Capital Management
Massachusetts
$5.88M +$8.33M +380,895 +349%
WA
2
Wasatch Advisors
Utah
$4.41M +$5.13M +234,744 +177%
TGHSA
3
TPG Group Holdings (SBS) Advisors
Texas
$3M – – –
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$1.92M +$3.5M +160,000 New
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.44M +$1.69M +77,348 +181%
BlackRock
6
BlackRock
New York
$1.23M +$2.23M +101,993 +112,080%
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$1.16M +$2.11M +96,405 New
Bank of America
8
Bank of America
North Carolina
$1.03M +$884K +40,446 +89%
DCM
9
DAFNA Capital Management
California
$869K – – –
RSCM
10
Rock Springs Capital Management
Maryland
$714K – – –
PC
11
Paulson & Co
New York
$600K +$1.09M +50,000 New
GIP
12
Granite Investment Partners
California
$539K +$226K +10,336 +30%
Russell Investments Group
13
Russell Investments Group
United Kingdom
$360K +$657K +30,069 New
State Street
14
State Street
Massachusetts
$314K +$69.8K +3,194 +14%
FPC
15
Falcon Point Capital
California
$313K +$571K +26,104 New
PAM
16
Panagora Asset Management
Massachusetts
$311K +$195K +8,929 +53%
RPAM
17
Rhenman & Partners Asset Management
Sweden
$281K – – –
KeyBank National Association
18
KeyBank National Association
Ohio
$265K +$331K +15,149 +218%
Northern Trust
19
Northern Trust
Illinois
$234K -$33.9K -1,550 -7%
Renaissance Technologies
20
Renaissance Technologies
New York
$200K -$302K -13,800 -45%
SI
21
Shaker Investments
Ohio
$190K – – –
Geode Capital Management
22
Geode Capital Management
Massachusetts
$186K +$19K +867 +6%
Group One Trading
23
Group One Trading
Illinois
$185K +$337K +15,417 New
MIM
24
Monashee Investment Management
Massachusetts
$180K – – –
Millennium Management
25
Millennium Management
New York
$162K +$295K +13,515 New
1
2 3 4

TNDM Hedge Fund Activity: Q1 2017 in Review

80 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2017, worth a combined $27.8M — up 5.9% from $26.2M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new TNDM positions and 12 closed out — a net gain of 9 holders — while 28 added to existing stakes and 14 trimmed.

The largest buyer was Frontier Capital Management, adding an estimated $8.33M. The largest seller was Eventide Asset Management, exiting entirely with an estimated $591K sold.

  • 80 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2017, up from 75 in Q4 2016.
  • Funds reported $27.8M of Tandem Diabetes Care stock for Q1 2017, up 5.9% quarter-over-quarter.
  • 21 funds opened new Tandem Diabetes Care positions in Q1 2017 and 12 closed out, a net change of +9 holders.
  • The largest Tandem Diabetes Care buyer in Q1 2017 was Frontier Capital Management, an estimated $8.33M added.
  • The largest Tandem Diabetes Care seller in Q1 2017 was Eventide Asset Management, an estimated $591K sold.

Based on aggregated 13F filings for Q1 2017.